查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1808953

生物假体市场（按产品、应用、国家和地区）－2025 年至 2032 年全球产业分析、市场规模、市场占有率及预测

Bioprosthetics Market, By Product, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年生物假体市场规模价值 59.48 亿美元，2025 年至 2032 年的复合年增长率为 4.80%。

生物假体是指利用生物材料製造义肢装置。这些装置通常用于替换或恢復受损或缺少的身体部位的功能。与通常由塑胶或金属等合成材料製成的传统义肢不同，生物义肢融入了组织或生物材料等天然元素，以更好地模拟人体部位的功能和结构。

生物假体市场-市场动态

再生医学方法的进展

再生医学的快速发展推动了生物假体（尤其是干细胞疗法和组织工程）的创新。这些技术能够製造出与天然组织非常相似的生物假体装置，进而改善整合性、功能性和患者的长期疗效。例如，2024年10月，研究人员成功利用干细胞衍生疗法治疗老年性黄斑部病变，显着改善了患者的视力。这项突破展示了再生方法在开发生物假体解决方案方面的潜力，这些解决方案能够恢復患者功能并改善生活品质。随着再生医学的进步，它有望在提高生物假体植入物的性能和使用寿命方面发挥重要作用，从而推动市场成长。

生物假体市场－关键见解

我们的研究分析师估计，2025 年至 2032 年间，全球市场将以约 4.80% 的复合年增长率成长。

根据产品细分，同种异体移植领域将在 2025 年占据市场主导地位。

根据应用领域，预计整形外科和伤口癒合在预测期内将经历显着的复合年增长率。

预计北美将在 2025 年引领市场。

生物假体市场-細項分析：

全球生物假体市场根据产品、应用和地区进行细分。

市场依产品分为两类：同种异体移植和异种移植。由于老年人口的成长和同种异体移植技术的进步，同种异体移植将在2025年占据市场主导地位。同种异体移植是指将组织或器官从一个个体移植到另一个同种异体。全球人口老化导致心血管疾病（CVD）发生率上升，组织修復成为必要。同种异体移植假体以其优异的植入物存活率和功能性而脱颖而出，从而改善了长期疗效。例如，Artivion, Inc. 的 CryoValve 主动脉同种异体移植包含完整的主动脉根部以及附着的二尖瓣前叶，提供了多种手术植入方案。

根据应用，市场分为两类：心血管领域和整形外科及伤口癒合领域。由于微创手术需求的成长和技术进步，预计预测期内整形外科及伤口癒合领域将实现显着的复合年增长率。根据美国整形外科医师协会 (ASPS) 的数据，男性美容手术整体成长了 6%。此外，微创技术的实施也对该领域的成长产生了正面的影响。此外，2023 年 ASPS 手术统计数据显示，美容手术的整体成长率为每年 5%。

生物假体市场—地理洞察

预计到2025年，北美将占据市场主导地位。推动这一增长的因素包括心血管疾病发病率的上升以及该地区完善的医疗设施。根据美国疾病管制与预防中心的数据，心血管疾病 (CVD) 仍然是美国主要的公共卫生问题，每33秒钟就有一人死于心血管疾病。这项令人担忧的统计数据凸显了心血管领域对更好生物瓣膜选择的需求。美国市场对北美的成长做出了重大贡献。这得归功于美国心臟病发病率的上升、医疗支出的增加以及主要的生物製药公司。此外，优惠的报销政策和大量的研发投入预计将加速市场成长。

预计亚太地区在预测期内的复合年增长率将位居前列。推动这快速成长的因素包括：替代疗法认知度的提升、医疗基础设施的快速发展，以及印度和中国等发展中国家在研发方面的投入。这些国家的政府措施旨在提高医疗服务的可及性和质量，从而支持区域成长潜力。中国的「健康中国2030」规划旨在改善健康状况，促进长寿。这可能会推动生物义肢等先进医疗技术的普及。

生物假体市场-竞争格局：

生物假体市场竞争激烈，主要受技术创新、材料进步以及微创手术需求不断增长的驱动。 LeMaitre Vascular, Inc.、Braile Biomedica、美敦力、Rua Life Sciences Plc（Aortech International Plc.）和LivaNova PLC（Sorin Group）凭藉其多样化的生物假体心臟瓣膜和血管移植物产品组合，占据了市场主导地位。这些公司透过投资研发、策略性收购和全球扩张来增强市场地位。新兴公司和新创公司也纷纷进入市场，推出创新的组织工程植入物和个人化生物假体解决方案。经导管主动脉瓣置换术 (TAVR) 的日益普及、监管机构的积极审批以及心血管和骨科疾病患病率的不断上升，正在加剧行业竞争，并加速行业创新。

最新动态：

2024年12月，印度医疗设备公司Meril Life Sciences新近推出了Myval Octapro经导管心臟瓣膜（THV），该产品已获得经导管主动脉瓣置换术（TAVR）的CE标誌认证。

目录

第一章：生物义肢市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 生物义肢市场产品片段
    • 生物假体市场片段（依应用）
    • 生物义肢市场（按国家/地区）
    • 生物义肢市场（按地区）
  • 竞争洞察

第三章：生物假体关键市场趋势

  • 生物义肢市场驱动因素
    • 市场驱动因素的影响分析
  • 生物义肢市场限制
    • 市场限制的影响分析
  • 生物义肢市场机会
  • 生物假体市场未来趋势

第四章：生物义肢产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：生物义肢市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：生物义肢市场格局

  • 2024年生物假体市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：生物义肢市场－依产品

  • 概述
    • 按产品细分的市占率分析
    • 同种异体移植
    • 异种移植

第 8 章：生物义肢市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 心血管
    • 整形外科和伤口癒合

第九章：生物义肢市场－按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美生物假体主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲生物假体主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按产品）
    • 欧洲市场规模和预测，按应用
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区生物假体主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品）
    • 亚太地区市场规模及预测（按应用）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲生物假体主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品）
    • 拉丁美洲市场规模及预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的生物假体主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品）
    • MEA 市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 10 章：主要供应商分析-生物假体产业

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • LeMaitre Vascular, Inc.
    • Braile Biomedica
    • Medtronic
    • Rua Life Sciences Plc (Aortech International Plc.)
    • LivaNova PLC (Sorin Group)
    • Organogenesis Inc.
    • Labcor Laboratories Ltda.
    • Humacyte Global, Inc.
    • Johnson & Johnson (Ethicon, Inc.)
    • Abbott (St. Jude Medical, Inc.)
    • Artivion, Inc. (CryoLife, Inc.)
    • Edwards Lifesciences Corporation.
    • JenaValve
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5595

Bioprosthetics Market size was valued at US$ 5,948 Million in 2024, expanding at a CAGR of 4.80% from 2025 to 2032.

Bioprosthetics is the use of biological materials in the manufacture of prosthetic devices. These devices are usually intended to replace or restore the functionality of damaged or missing body parts. Unlike traditional prosthetics, which are typically made of synthetic materials such as plastics or metals, bioprosthetics incorporate natural elements such as tissues or biomaterials to better mimic the function and structure of human body parts.

Bioprosthetics Market- Market Dynamics

Advances in regenerative medicine approaches

Rapid advances in regenerative medicine are driving innovation in bioprosthetics, particularly stem cell therapy and tissue engineering. These techniques enable the creation of bioprosthetic devices that closely resemble natural tissues, thereby improving integration, functionality, and long-term patient outcomes. For instance, in October 2024, researchers successfully used stem cell-derived therapies to treat age-related macular degeneration, significantly improving patients' vision. This breakthrough demonstrates the potential of regenerative approaches for developing bioprosthetic solutions that restore function and improve quality of life. As regenerative medicine advances, it is expected to play an important role in improving the performance and longevity of bioprosthetic implants, thereby driving market growth.

Bioprosthetics Market- Key Insights

Our research analyst estimates that the global market will grow at a CAGR of approximately 4.80% between 2025 and 2032.

Based on Product segmentation, the allograft segment dominates the market in 2025.

According to the application segment, Plastic surgery and wound healing are expected to experience significant CAGR growth during the forecast period.

North America is anticipated to lead the market in 2025.

Bioprosthetics Market- Segmentation Analysis:

The Global Bioprosthetics Market is segmented on the basis of Product, Application, and Region.

The market is divided into two categories based on Product: Allograft, and Xenograft. The allograft segment will dominate the market in 2025, owing to an increasing geriatric population and advances in allograft procedures. An allograft is a tissue or organ transplant from one individual to another of the same species. The world's aging population is contributing to an increase in CVD, necessitating tissue repair. The allograft prosthesis stands out for its excellent implant survival and functional performance, which improves long-term outcomes. For instance, Artivion, Inc.'s CryoValve AORTIC ALLOGRAFT includes a complete aortic root as well as the attached anterior mitral leaflet, providing several surgical implantation options.

The market is divided into two categories based on application: Cardiovascular, and Plastic surgery & wound healing. The plastic surgery and wound healing segment is expected to grow at a significant CAGR during the forecast period, owing to increased demand for minimally invasive surgery and technological advancement. According to the American Society of Plastic Surgeons (ASPS), overall cosmetic procedures performed on men increased by 6%. Furthermore, implementing minimally invasive techniques is having a positive impact on segment growth. Furthermore, the 2023 ASPS Procedural Statistics show that overall growth in cosmetic surgery procedures has increased by 5% per year.

Bioprosthetics Market- Geographical Insights

In 2025, North America is expected to dominate the market. Factors driving this growth include rising cardiovascular disease rates and established healthcare facilities in the region. According to the Centers for Disease Control and Prevention, cardiovascular disease (CVD) remains a major public health concern in the United States, with one person dying from it every 33 seconds. This alarming statistic highlights the need for better bioprosthetic heart valve options in the cardiovascular sector. The U.S. market has significantly contributed to growth in North America. This is due to rising heart disease, increased healthcare spending, and key biopharma companies in the country. Furthermore, favorable reimbursement policies and significant R&D investments are expected to accelerate market growth.

The Asia Pacific region is expected to have the fastest CAGR during the forecast period. This rapid growth is driven by increased awareness of alternative treatments, rapidly developing healthcare infrastructure, and increased engagement in research and development in developing countries like India and China. Government initiatives in these countries aim to improve healthcare accessibility and quality, which supports regional growth potential. China's Healthy China 2030 plan aims to improve health and promote longevity. This may lead to increased adoption of advanced medical technologies, such as bioprosthetics.

Bioprosthetics Market- Competitive Landscape:

The bioprosthetics market is highly competitive, driven by technological innovation, material advancements, and rising demand for minimally invasive procedures. LeMaitre Vascular, Inc., Braile Biomedica, Medtronic, Rua Life Sciences Plc (Aortech International Plc.), and LivaNova PLC (Sorin Group) dominate the market with a diverse portfolio of bioprosthetic heart valves and vascular grafts. These companies compete by investing in R&D, making strategic acquisitions, and expanding globally to strengthen their market position. New companies and startups are also entering the market with innovative tissue-engineered implants and personalized bioprosthetic solutions. The growing use of transcatheter aortic valve replacement (TAVR), favorable regulatory approvals, and rising prevalence of cardiovascular and orthopedic conditions are increasing competition and accelerating innovation in the industry.

Recent Developments:

In December 2024, Meril Life Sciences, an Indian medical equipment company, recently introduced the Myval Octapro transcatheter heart valve (THV), which has received CE mark approval for transcatheter aortic valve replacement (TAVR).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPROSTHETICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • LeMaitre Vascular, Inc.
  • Braile Biomedica
  • Medtronic
  • Rua Life Sciences Plc (Aortech International Plc.)
  • LivaNova PLC (Sorin Group)
  • Organogenesis Inc.
  • Labcor Laboratories Ltda.
  • Humacyte Global, Inc.
  • Johnson & Johnson (Ethicon, Inc.)
  • Abbott (St. Jude Medical, Inc.)
  • Artivion, Inc. (CryoLife, Inc.)
  • Edwards Lifesciences Corporation.
  • JenaValve
  • Others

GLOBAL BIOPROSTHETICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Allograft
  • Xenograft

GLOBAL BIOPROSTHETICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular
  • Plastic surgery & wound healing

GLOBAL BIOPROSTHETICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bioprosthetics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bioprosthetics Market Snippet by Product
    • 2.1.2. Bioprosthetics Market Snippet by Application
    • 2.1.3. Bioprosthetics Market Snippet by Country
    • 2.1.4. Bioprosthetics Market Snippet by Region
  • 2.2. Competitive Insights

3. Bioprosthetics Key Market Trends

  • 3.1. Bioprosthetics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bioprosthetics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bioprosthetics Market Opportunities
  • 3.4. Bioprosthetics Market Future Trends

4. Bioprosthetics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bioprosthetics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Bioprosthetics Market Landscape

  • 6.1. Bioprosthetics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bioprosthetics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Allograft
    • 7.1.3. Xenograft

8. Bioprosthetics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Cardiovascular
    • 8.1.3. Plastic surgery & wound healing

9. Bioprosthetics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Bioprosthetics Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Bioprosthetics Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7. UK
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.7.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8. France
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9. Italy
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10. Spain
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.10.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11. The Netherlands
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.11.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Overview
      • 9.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.12.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13. Russia
      • 9.3.13.1. Overview
      • 9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.13.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Bioprosthetics Key Manufacturers in Asia Pacific
    • 9.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6. China
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.6.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11. Indonesia
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12. Thailand
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5. Latin America (LATAM)
    • 9.5.1. Overview
    • 9.5.2. Bioprosthetics Key Manufacturers in Latin America
    • 9.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa (MEA)
    • 9.6.1. Overview
    • 9.6.2. Bioprosthetics Key Manufacturers in Middle East and Africa
    • 9.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7. UAE
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.7.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Bioprosthetics Industry

  • 10.1. Competitive Benchmarking
    • 10.1.1. Competitive Dashboard
    • 10.1.2. Competitive Positioning
  • 10.2. Company Profiles
    • 10.2.1. LeMaitre Vascular, Inc.
    • 10.2.2. Braile Biomedica
    • 10.2.3. Medtronic
    • 10.2.4. Rua Life Sciences Plc (Aortech International Plc.)
    • 10.2.5. LivaNova PLC (Sorin Group)
    • 10.2.6. Organogenesis Inc.
    • 10.2.7. Labcor Laboratories Ltda.
    • 10.2.8. Humacyte Global, Inc.
    • 10.2.9. Johnson & Johnson (Ethicon, Inc.)
    • 10.2.10. Abbott (St. Jude Medical, Inc.)
    • 10.2.11. Artivion, Inc. (CryoLife, Inc.)
    • 10.2.12. Edwards Lifesciences Corporation.
    • 10.2.13. JenaValve
    • 10.2.14. Others

11. 360 Degree AnalystView

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us